Pregnancy and SARS-CoV-2 infection with a focus on its vertical transmission, breastfeeding, cord blood banking, and vaccination during COVID-19 infection

The SARS-CoV-2 outbreak led to a health crisis worldwide. This infection can infect individuals, particularly pregnant women. In this review, we tried to find the possibility of vertical transmission of COVID-19 and investigate the effects of COVID-19 on pregnancy, breastfeeding, cord blood banking, and the effects of recommended vaccines on pregnant and lactating women. Keywords include COVID-19, congenital infection, SARS-CoV-2, pregnancy, and COVID-19 vaccines. Vertical transmission of SARS-CoV-2 was searched in scientific databases, such as PubMed, Google Scholar, and Scopus. The criteria for including studies in this article are the study of SARS-CoV-2 infection in pregnant women, fetuses, and neonates during pregnancy and while breastfeeding, and also the effect of COVID-19 vaccines on them. There are several conflicting results in the transmission of SARS-CoV-2 from the maternal-fetal interface. Since many neonates born from COVID-19-infected mothers had no signs of this infection, the possibility of SARS-CoV-2 congenital transmission cannot be confirmed. Also, SARS-CoV-2-infected women can breastfeed their babies if they have mild symptoms. Up till now, no adverse effect of COVID-19 vaccines has been identified on mothers, infants, and the fertility of men or women. Even so, more investigations are needed on the long-term effects of COVID-19 vaccines.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:44

Enthalten in:

Journal of immunoassay & immunochemistry - 44(2023), 5-6 vom: 02. Nov., Seite 361-380

Sprache:

Englisch

Beteiligte Personen:

Ketabi, Kiana [VerfasserIn]
Soleimanjahi, Hoorieh [VerfasserIn]
Habibian, Ala [VerfasserIn]
Abroun, Saied [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
COVID-19 Vaccines
COVID-19 vaccines
Congenital infection
Journal Article
Pregnancy
Review
SARS-CoV-2

Anmerkungen:

Date Completed 02.11.2023

Date Revised 02.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/15321819.2023.2259454

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362884854